Pharma Focus Asia
KP - Choose our fully recyclable blister films

TECARTUS™ Discovered for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Kite discovered Tecartus™ (brexucabtageneautoleucel, formerly KTE-X19), a novel Chimeric Antigen Receptor (CAR) T for the treatment of adult patients with relapsed or refractory Mantle Cell Lymphoma (MCL).

Tecartus is a CD19-directed genetically modified autologous T cell immunotherapy suitable for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). Hence, the newly approved CAR T cell therapy for mantle cell lymphoma patients indicates a new frontier in the treatment of this disease.

MCL is a rare type of cancerous B-cell non-Hodgkin lymphoma that typically grows from cells that reside in the lymph nodes mantle region and mainly affecting middle-aged or older adults.Most of the patients experience frequent relapse after initial treatment and moreover the cause of MCL is unknownand at the same time it is incurable.

Some of the adverse symptomsof patients with MCL include painless swelling in the armpit, neck or groin region, unexplained weight loss, night sweats, fever with no obvious cause, anaemia, diarrhoea, loss of appetite, sickness (nausea) and easy bruising or bleeding.

U.S.Food and Drug Administration (FDA) grants Tecartus™ (brexucabtageneautoleucel, formerly KTE-X19) the first and only approved CAR T cell therapy for treating relapsed or refractory mantle cell lymphoma (r / r MCL).

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS